{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:05:06Z","timestamp":1791068706603,"version":"4.1.0"},"reference-count":135,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00005-019-00550-9","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T09:03:19Z","timestamp":1559725399000},"page":"197-211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases"],"prefix":"10.2478","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7075-8464","authenticated-orcid":false,"given":"George N.","family":"Dalekos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos K.","family":"Gatselis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"key":"550_CR1","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1055\/s-0043-107029","volume":"49","author":"L Aabakken","year":"2017","unstructured":"Aabakken L, Karlsen TH, Albert J et al (2017) Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Endoscopy 49:588\u2013608","journal-title":"Endoscopy"},{"key":"550_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jhep.2012.10.013","volume":"58","author":"S Al Mamari","year":"2013","unstructured":"Al Mamari S, Djordjevic J, Halliday JS et al (2013) Improvement of serum alkaline phosphatase to\u2009<\u20091.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol 58:329\u2013334","journal-title":"J Hepatol"},{"key":"550_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","volume":"28","author":"T Al-Chalabi","year":"2008","unstructured":"Al-Chalabi T, Portmann BC, Bernal W et al (2008) Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival. Aliment Pharmacol Ther 28:209\u2013220","journal-title":"Aliment Pharmacol Ther"},{"key":"550_CR4","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1097\/MCG.0b013e3181f18c4e","volume":"45","author":"AH Ali","year":"2011","unstructured":"Ali AH, Sinakos E, Silveira MG et al (2011) Varices in early histological stage primary biliary cirrhosis. J Clin Gastroenterol 45:e66\u2013e71","journal-title":"J Clin Gastroenterol"},{"key":"550_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929\u2013938","journal-title":"J Hepatol"},{"key":"550_CR6","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","volume":"35","author":"P Angulo","year":"2002","unstructured":"Angulo P, Maor-Kendler Y, Lindor KD (2002) Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology 35:1494\u20131500","journal-title":"Hepatology"},{"key":"550_CR7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.dld.2014.06.010","volume":"46","author":"M Benito de Valle","year":"2014","unstructured":"Benito de Valle M, Muller T, Bjornsson E et al (2014) The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitis. Dig Liver Dis 46:903\u2013908","journal-title":"Dig Liver Dis"},{"key":"550_CR8","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1053\/j.gastro.2015.01.041","volume":"148","author":"NL Berntsen","year":"2015","unstructured":"Berntsen NL, Klingenberg O, Juran BD et al (2015) Association between HLA haplotypes and increased serum levels of IgG4 in patients with primary sclerosing cholangitis. Gastroenterology 148:924\u2013927","journal-title":"Gastroenterology"},{"key":"550_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12016-010-8234-y","volume":"42","author":"N Bizzaro","year":"2012","unstructured":"Bizzaro N, Covini G, Rosina F et al (2012) Overcoming a \u201cprobable\u201d diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature. Clin Rev Allergy Immunol 42:288\u2013297","journal-title":"Clin Rev Allergy Immunol"},{"key":"550_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11894-009-0006-6","volume":"11","author":"E Bjornsson","year":"2009","unstructured":"Bjornsson E (2009) Small-duct primary sclerosing cholangitis. Curr Gastroenterol Rep 11:37\u201341","journal-title":"Curr Gastroenterol Rep"},{"key":"550_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/gut.51.5.731","volume":"51","author":"E Bjornsson","year":"2002","unstructured":"Bjornsson E, Boberg KM, Cullen S et al (2002) Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 51:731\u2013735","journal-title":"Gut"},{"key":"550_CR12","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","volume":"134","author":"E Bjornsson","year":"2008","unstructured":"Bjornsson E, Olsson R, Bergquist A et al (2008) The natural history of small-duct primary sclerosing cholangitis. Gastroenterology 134:975\u2013980","journal-title":"Gastroenterology"},{"key":"550_CR13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","volume":"54","author":"KM Boberg","year":"2011","unstructured":"Boberg KM, Chapman RW, Hirschfield GM et al (2011) Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 54:374\u2013385","journal-title":"J Hepatol"},{"key":"550_CR14","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/hep.21678","volume":"45","author":"DP Bogdanos","year":"2007","unstructured":"Bogdanos DP, Liaskos C, Pares A et al (2007) Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology 45:1583\u20131584","journal-title":"Hepatology"},{"key":"550_CR15","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra K, Weersma RK, van Erpecum KJ et al (2013) Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 58:2045\u20132055","journal-title":"Hepatology"},{"key":"550_CR16","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/hep.26977","volume":"59","author":"K Boonstra","year":"2014","unstructured":"Boonstra K, Culver EL, de Buy Wenniger LM et al (2014) Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology 59:1954\u20131963","journal-title":"Hepatology"},{"key":"550_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/gut.2004.040832","volume":"54","author":"B Bressler","year":"2005","unstructured":"Bressler B, Pinto R, El-Ashry D, Heathcote EJ (2005) Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection? Gut 54:407\u2013410","journal-title":"Gut"},{"key":"550_CR18","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","volume":"386","author":"EJ Carey","year":"2015","unstructured":"Carey EJ, Ali AH, Lindor KD (2015) Primary biliary cirrhosis. Lancet 386:1565\u20131575","journal-title":"Lancet"},{"key":"550_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.510280203","volume":"28","author":"O Chazouilleres","year":"1998","unstructured":"Chazouilleres O, Wendum D, Serfaty L et al (1998) Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 28:296\u2013301","journal-title":"Hepatology"},{"key":"550_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","volume":"44","author":"O Chazouilleres","year":"2006","unstructured":"Chazouilleres O, Wendum D, Serfaty L et al (2006) Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol 44:400\u2013406","journal-title":"J Hepatol"},{"key":"550_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1665-2681(19)31388-2","volume":"12","author":"HW Chen","year":"2013","unstructured":"Chen HW, Huang HH, Lai CH et al (2013) Hepatitis C virus infection in patients with primary biliary cirrhosis. Ann Hepatol 12:78\u201384","journal-title":"Ann Hepatol"},{"key":"550_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","volume":"53","author":"C Corpechot","year":"2010","unstructured":"Corpechot C, Chretien Y, Chazouilleres O et al (2010) Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol 53:162\u2013169","journal-title":"J Hepatol"},{"key":"550_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/hep.28859","volume":"65","author":"G Dahlqvist","year":"2017","unstructured":"Dahlqvist G, Gaouar F, Carrat F et al (2017) Large-scale characterization study of patients with antimitochondrial antibodies but non established primary biliary cholangitis. Hepatology 65:152\u2013163","journal-title":"Hepatology"},{"key":"550_CR24","first-page":"179","volume":"6","author":"GN Dalekos","year":"1995","unstructured":"Dalekos GN, Skopouli FN, Tsianos EV (1995) Primary biliary cirrhosis associated with anticardiolipin syndrome. Eur J Intern Med 6:179\u2013181","journal-title":"Eur J Intern Med"},{"key":"550_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.12970\/2310-9874.2018.06.04","volume":"6","author":"GN Dalekos","year":"2018","unstructured":"Dalekos GN, Lygoura V, Gatselis NK (2018) Variants of primary biliary cholangitis: an updated mini-review. J Autoimmune Dis Rheumatol 6:21\u201328","journal-title":"J Autoimmune Dis Rheumatol"},{"key":"550_CR26","first-page":"1","volume":"32","author":"GN Dalekos","year":"2019","unstructured":"Dalekos GN, Koskinas J, Papatheodoridis GV (2019) Hellenic Association for the Study of the Liver (HASL) clinical practice guidelines: autoimmune hepatitis. Ann Gastroenterol 32:1\u201323","journal-title":"Ann Gastroenterol"},{"key":"550_CR27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R (2015) Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 63:743\u2013752","journal-title":"J Hepatol"},{"key":"550_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/hep.29204","volume":"66","author":"MR Deneau","year":"2017","unstructured":"Deneau MR, El-Matary W, Valentino PL et al (2017) The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration. Hepatology 66:518\u2013527","journal-title":"Hepatology"},{"key":"550_CR29","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cgh.2012.02.010","volume":"10","author":"AM Dinani","year":"2012","unstructured":"Dinani AM, Fischer SE, Mosko J, Guindi M et al (2012) Patients with autoimmune hepatitis who have antimitochondrial antibodies need long-term follow-up to detect late development of primary biliary cirrhosis. Clin Gastroenterol Hepatol 10:682\u2013684","journal-title":"Clin Gastroenterol Hepatol"},{"key":"550_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/hep.28568","volume":"64","author":"ME Doorenspleet","year":"2016","unstructured":"Doorenspleet ME, Hubers LM, Culver EL et al (2016) Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary\/pancreatic malignancies. Hepatology 64:501\u2013507","journal-title":"Hepatology"},{"key":"550_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/apt.15111","volume":"49","author":"JK Dyson","year":"2019","unstructured":"Dyson JK, De Martin E, Dalekos GN et al (2019) Review article: unanswered clinical and research questions in autoimmune hepatitis: conclusions of the International Autoimmune Hepatitis Group Research Workshop. Aliment Pharmacol Ther 49:528\u2013536","journal-title":"Aliment Pharmacol Ther"},{"key":"550_CR32","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","volume":"63","author":"European Association for the Study of the Liver","year":"2015","unstructured":"European Association for the Study of the Liver (2015) EASL Clinical Practice Guidelines: autoimmune hepatitis. J Hepatol 63:971\u20131004","journal-title":"J Hepatol"},{"key":"550_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver (2017a) EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67:145\u2013172","journal-title":"J Hepatol"},{"key":"550_CR34","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver (2017b) EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 67:370\u2013398","journal-title":"J Hepatol"},{"key":"550_CR35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver (2018) EASL Recommendations on treatment of hepatitis C 2018. J Hepatol 69:461\u2013511","journal-title":"J Hepatol"},{"key":"550_CR36","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1478-3231.2009.01986.x","volume":"29","author":"V Eyraud","year":"2009","unstructured":"Eyraud V, Chazouilleres O, Ballot E et al (2009) Significance of antibodies to soluble liver antigen\/liver pancreas: a large French study. Liver Int 29:857\u2013864","journal-title":"Liver Int"},{"key":"550_CR37","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1111\/j.1572-0241.2003.08717.x","volume":"98","author":"A Floreani","year":"2003","unstructured":"Floreani A, Baragiotta A, Leone MG et al (2003) Primary biliary cirrhosis and hepatitis C virus infection. Am J Gastroenterol 98:2757\u20132762","journal-title":"Am J Gastroenterol"},{"key":"550_CR38","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","volume":"100","author":"A Floreani","year":"2005","unstructured":"Floreani A, Rizzotto ER, Ferrara F et al (2005) Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol 100:1516\u20131522","journal-title":"Am J Gastroenterol"},{"key":"550_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1478-3231.2010.02366.x","volume":"31","author":"A Floreani","year":"2011","unstructured":"Floreani A, Caroli D, Variola A et al (2011) A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver Int 31:361\u2013368","journal-title":"Liver Int"},{"key":"550_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12016-014-8427-x","volume":"48","author":"A Floreani","year":"2015","unstructured":"Floreani A, Franceschet I, Cazzagon N et al (2015a) Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol 48:192\u2013197","journal-title":"Clin Rev Allergy Immunol"},{"key":"550_CR41","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.dld.2015.02.002","volume":"47","author":"A Floreani","year":"2015","unstructured":"Floreani A, Motta R, Cazzagon N et al (2015b) The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. Dig Liver Dis 47:432\u2013435","journal-title":"Dig Liver Dis"},{"key":"550_CR42","doi-asserted-by":"publisher","first-page":"8654","DOI":"10.1073\/pnas.85.22.8654","volume":"85","author":"SP Fussey","year":"1988","unstructured":"Fussey SP, Guest JR, James OF et al (1988) Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 85:8654\u20138658","journal-title":"Proc Natl Acad Sci USA"},{"key":"550_CR43","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s10875-007-9092-0","volume":"27","author":"S Gabeta","year":"2007","unstructured":"Gabeta S, Norman GL, Liaskos C et al (2007) Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol 27:378\u2013387","journal-title":"J Clin Immunol"},{"key":"550_CR44","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1080\/14737159.2016.1217159","volume":"16","author":"NK Gatselis","year":"2016","unstructured":"Gatselis NK, Dalekos GN (2016) Molecular diagnostic testing for primary biliary cholangitis. Expert Rev Mol Diagn 16:1001\u20131010","journal-title":"Expert Rev Mol Diagn"},{"key":"550_CR45","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1478-3231.2006.01402.x","volume":"27","author":"NK Gatselis","year":"2007","unstructured":"Gatselis NK, Stefos A, Gioti C et al (2007) Primary biliary cirrhosis and Henoch-Schonlein purpura: report of two cases and review of the literature. Liver Int 27:280\u2013283","journal-title":"Liver Int"},{"key":"550_CR46","doi-asserted-by":"crossref","unstructured":"Gatselis NK, Zachou K, Dalekos GN (2010a) Early primary biliary cirrhosis: a new association with erythema nodosum of unknown origin. Gastroenterol Res Pract 2010:121620","DOI":"10.1155\/2010\/121620"},{"key":"550_CR47","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.dld.2010.03.005","volume":"42","author":"NK Gatselis","year":"2010","unstructured":"Gatselis NK, Zachou K, Papamichalis P et al (2010b) Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score? Dig Liver Dis 42:807\u2013812","journal-title":"Dig Liver Dis"},{"key":"550_CR48","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3109\/08916934.2013.801461","volume":"46","author":"NK Gatselis","year":"2013","unstructured":"Gatselis NK, Zachou K, Norman GL et al (2013) Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease. Autoimmunity 46:471\u2013479","journal-title":"Autoimmunity"},{"key":"550_CR49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","volume":"21","author":"NK Gatselis","year":"2015","unstructured":"Gatselis NK, Zachou K, Koukoulis GK et al (2015) Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol 21:60\u201383","journal-title":"World J Gastroenterol"},{"key":"550_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejim.2017.05.006","volume":"42","author":"NK Gatselis","year":"2017","unstructured":"Gatselis NK, Zachou K, Lygoura V et al (2017) Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece. Eur J Intern Med 42:81\u201388","journal-title":"Eur J Intern Med"},{"key":"550_CR51","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","volume":"138","author":"ME Gershwin","year":"1987","unstructured":"Gershwin ME, Mackay IR, Sturgess A et al (1987) Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138:3525\u20133531","journal-title":"J Immunol"},{"key":"550_CR52","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/hep.20907","volume":"42","author":"ME Gershwin","year":"2005","unstructured":"Gershwin ME, Selmi C, Worman HJ et al (2005) Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42:1194\u20131202","journal-title":"Hepatology"},{"key":"550_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1586\/erm.11.82","volume":"12","author":"A Granito","year":"2012","unstructured":"Granito A, Muratori P, Quarneti C et al (2012) Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Rev Mol Diagn 12:65\u201374","journal-title":"Expert Rev Mol Diagn"},{"key":"550_CR54","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1053\/jhep.2001.22131","volume":"33","author":"GV Gregorio","year":"2001","unstructured":"Gregorio GV, Portmann B, Karani J et al (2001) Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 33:544\u2013553","journal-title":"Hepatology"},{"key":"550_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/cld.317","volume":"3","author":"D Haldar","year":"2014","unstructured":"Haldar D, Hirschfield GM (2014) Overlap syndrome: a real syndrome? Clin Liver Dis 3:43\u201347","journal-title":"Clin Liver Dis"},{"key":"550_CR56","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.crohns.2011.07.015","volume":"6","author":"JS Halliday","year":"2012","unstructured":"Halliday JS, Djordjevic J, Lust M et al (2012) A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn\u2019s disease. J Crohns Colitis 6:174\u2013181","journal-title":"J Crohns Colitis"},{"key":"550_CR57","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/ajg.2017.440","volume":"113","author":"MH Harms","year":"2018","unstructured":"Harms MH, Lammers WJ, Thorburn D et al (2018) Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: risk factors and time trends in incidence and outcome. Am J Gastroenterol 113:254\u2013264","journal-title":"Am J Gastroenterol"},{"key":"550_CR58","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Topazian MD, Witzig TE et al (2013) Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 62:1607\u20131615","journal-title":"Gut"},{"key":"550_CR59","first-page":"2012","volume":"35","author":"GS Hatzis","year":"2008","unstructured":"Hatzis GS, Fragoulis GE, Karatzaferis A et al (2008) Prevalence and longterm course of primary biliary cirrhosis in primary Sj\u00f6gren\u2019s syndrome. J Rheumatol 35:2012\u20132016","journal-title":"J Rheumatol"},{"key":"550_CR60","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169\u2013176","journal-title":"Hepatology"},{"key":"550_CR61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0399-8320(07)89323-7","volume":"31","author":"A Heurgue","year":"2007","unstructured":"Heurgue A, Vitry F, Diebold MD et al (2007) Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroenterol Clin Biol 31:17\u201325","journal-title":"Gastroenterol Clin Biol"},{"key":"550_CR62","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.cld.2008.02.003","volume":"12","author":"GM Hirschfield","year":"2008","unstructured":"Hirschfield GM, Heathcote EJ (2008) Antimitochondrial antibody-negative primary biliary cirrhosis. Clin Liver Dis 12:323\u2013331","journal-title":"Clin Liver Dis"},{"key":"550_CR63","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","volume":"67","author":"GM Hirschfield","year":"2018","unstructured":"Hirschfield GM, Dyson JK, Alexander GJM et al (2018) The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut 67:1568\u20131594","journal-title":"Gut"},{"key":"550_CR64","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.4254\/wjh.v8.i33.1419","volume":"8","author":"YQ Huang","year":"2016","unstructured":"Huang YQ (2016) Recent advances in the diagnosis and treatment of primary biliary cholangitis. Word J Hepatol 8:1419\u20131441","journal-title":"Word J Hepatol"},{"key":"550_CR65","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00795-013-0048-6","volume":"47","author":"H Iguchi","year":"2014","unstructured":"Iguchi H, Oda M, Yamazaki H et al (2014) Aquaporin-1 is associated with arterial capillary proliferation and hepatic sinusoidal transformation contributing to portal hypertension in primary biliary cirrhosis. Med Mol Morphol 47:90\u201399","journal-title":"Med Mol Morphol"},{"key":"550_CR66","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/j.1440-1746.2012.07114.x","volume":"27","author":"F Ikeda","year":"2012","unstructured":"Ikeda F, Okamoto R, Baba N et al (2012) Prevalence and associated factors with esophageal varices in early primary biliary cirrhosis. J Gastroenterol Hepatol 27:1320\u20131328","journal-title":"J Gastroenterol Hepatol"},{"key":"550_CR67","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0168-8278(00)00040-4","volume":"34","author":"P Invernizzi","year":"2001","unstructured":"Invernizzi P, Podda M, Battezzati PM et al (2001) Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 34:366\u2013372","journal-title":"J Hepatol"},{"key":"550_CR68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jhbp.596","volume":"26","author":"T Kamisawa","year":"2019","unstructured":"Kamisawa T, Nakazawa T, Tazuma S et al (2019) Clinical practice guidelines for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci 26:9\u201342","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"550_CR69","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1055\/s-2001-12906","volume":"126","author":"S Kanzler","year":"2001","unstructured":"Kanzler S, Bozkurt S, Herkel J et al (2001) Presence of SLA\/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome). Dtsch Med Wochenschr 126:450\u2013456","journal-title":"Dtsch Med Wochenschr"},{"key":"550_CR70","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D et al (2017) Primary sclerosing cholangitis\u2014a comprehensive review. J Hepatol 67:1298\u20131323","journal-title":"J Hepatol"},{"key":"550_CR71","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cgh.2010.03.004","volume":"8","author":"EM Kuiper","year":"2010","unstructured":"Kuiper EM, Zondervan PE, van Buuren HR (2010) Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol 8:530\u2013534","journal-title":"Clin Gastroenterol Hepatol"},{"key":"550_CR72","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","volume":"149","author":"WJ Lammers","year":"2015","unstructured":"Lammers WJ, Hirschfield GM, Corpechot C et al (2015) Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology 149:1804\u20131812","journal-title":"Gastroenterology"},{"key":"550_CR73","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMra1506330","volume":"375","author":"KN Lazaridis","year":"2016","unstructured":"Lazaridis KN, LaRusso NF (2016) Primary sclerosing cholangitis. N Engl J Med 375:1161\u20131170","journal-title":"N Engl J Med"},{"key":"550_CR74","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cgh.2007.02.031","volume":"5","author":"C Levy","year":"2007","unstructured":"Levy C, Zein CO, Gomez J et al (2007) Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol 5:803\u2013808","journal-title":"Clin Gastroenterol Hepatol"},{"key":"550_CR75","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cgh.2013.12.010","volume":"12","author":"C Levy","year":"2014","unstructured":"Levy C, Naik J, Giordano C et al (2014) Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics. Clin Gastroenterol Hepatol 12:1398\u20131405","journal-title":"Clin Gastroenterol Hepatol"},{"key":"550_CR76","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/hep.23024","volume":"50","author":"M Lewin","year":"2009","unstructured":"Lewin M, Vilgrain V, Ozenne V et al (2009) Prevalence of sclerosing cholangitis in adults with\u00a0autoimmune hepatitis: a prospective magnetic resonance imaging and histological study. Hepatology 50:528\u2013537","journal-title":"Hepatology"},{"key":"550_CR77","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1440-1746.2006.04751.x","volume":"22","author":"C Liaskos","year":"2007","unstructured":"Liaskos C, Bogdanos DP, Rigopoulou EI et al (2007) Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact? J Gastroenterol Hepatol 22:454\u2013455","journal-title":"J Gastroenterol Hepatol"},{"key":"550_CR78","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cca.2009.12.012","volume":"411","author":"C Liaskos","year":"2010","unstructured":"Liaskos C, Norman GL, Moulas A et al (2010) Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis. Clin Chim Acta 411:411\u2013415","journal-title":"Clin Chim Acta"},{"key":"550_CR79","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ajg.2015.112","volume":"110","author":"KD Lindor","year":"2015","unstructured":"Lindor KD, Kowdley KV, Harrison ME (2015) ACG Clinical Guideline: primary sclerosing cholangitis. Am J Gastroenterol 110:646\u2013659","journal-title":"Am J Gastroenterol"},{"key":"550_CR80","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cgh.2012.12.032","volume":"11","author":"L Lindstrom","year":"2013","unstructured":"Lindstrom L, Hultcrantz R, Boberg KM et al (2013) Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 11:841\u2013846","journal-title":"Clin Gastroenterol Hepatol"},{"key":"550_CR81","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","volume":"35","author":"H Liu","year":"2010","unstructured":"Liu H, Norman GL, Shums Z et al (2010) PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun 35:436\u2013442","journal-title":"J Autoimmun"},{"key":"550_CR82","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/hep.510290409","volume":"29","author":"AW Lohse","year":"1999","unstructured":"Lohse AW, Zum B\u03cbschenfelde KH, Franz B et al (1999) Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 29:1078\u20131084","journal-title":"Hepatology"},{"issue":"660\u2013669","key":"550_CR83","first-page":"e4","volume":"151","author":"AK Lunder","year":"2016","unstructured":"Lunder AK, Hov JR, Borthne A et al (2016) Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease. Gastroenterology 151(660\u2013669):e4","journal-title":"Gastroenterology"},{"key":"550_CR84","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","volume":"43","author":"S Luth","year":"2009","unstructured":"Luth S, Kanzler S, Frenzel C et al (2009) Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome. J Clin Gastroenterol 43:75\u201380","journal-title":"J Clin Gastroenterol"},{"key":"550_CR85","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MEG.0000000000000268","volume":"27","author":"H Maruyama","year":"2015","unstructured":"Maruyama H, Kondo T, Sekimoto T et al (2015) Retrograde detection of the intrahepatic portal vein in primary biliary cirrhosis: is sinusoidal blockage the underlying pathophysiology? Eur J Gastroenterol Hepatol 27:321\u2013327","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"550_CR86","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/hep.510270303","volume":"27","author":"A Mattalia","year":"1998","unstructured":"Mattalia A, Quaranta S, Leung PS et al (1998) Characterization of antimitochondrial antibodies in health adults. Hepatology 27:656\u2013661","journal-title":"Hepatology"},{"key":"550_CR87","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/hep.26365","volume":"58","author":"GF Mells","year":"2013","unstructured":"Mells GF, Pells G, Newton JL et al (2013) Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study. Hepatology 58:273\u2013283","journal-title":"Hepatology"},{"key":"550_CR88","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.gtc.2008.02.006","volume":"37","author":"F Mendes","year":"2008","unstructured":"Mendes F, Lindor KD (2008) Antimitochondrial antibody-negative primary biliary cirrhosis. Gastroenterol Clin North Am 37:479\u2013484","journal-title":"Gastroenterol Clin North Am"},{"key":"550_CR89","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","volume":"348","author":"JV Metcalf","year":"1996","unstructured":"Metcalf JV, Mitchinson HC, Palmer JM et al (1996) Natural history of early primary biliary cirrhosis. Lancet 348:1399\u20131402","journal-title":"Lancet"},{"key":"550_CR90","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","volume":"66","author":"G Mieli-Vergani","year":"2018","unstructured":"Mieli-Vergani G, Vergani D, Baumann U et al (2018) Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement. J Pediatr Gastroenterol Nutr 66:345\u2013360","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"550_CR91","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/hep.1840060609","volume":"6","author":"HC Mitchison","year":"1986","unstructured":"Mitchison HC, Bassendine MF, Hendrick A et al (1986) Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology 6:1279\u20131284","journal-title":"Hepatology"},{"key":"550_CR92","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/MCG.0b013e3181587d18","volume":"42","author":"AJ Montano-Loza","year":"2008","unstructured":"Montano-Loza AJ, Carpenter HA, Czaja AJ (2008) Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis. J Clin Gastroenterol 42:1047\u20131053","journal-title":"J Clin Gastroenterol"},{"key":"550_CR93","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/ajg.2009.126","volume":"104","author":"P Muratori","year":"2009","unstructured":"Muratori P, Granito A, Pappas G et al (2009) The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol 104:1420\u20131425","journal-title":"Am J Gastroenterol"},{"key":"550_CR94","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/MEG.0000000000000870","volume":"29","author":"P Muratori","year":"2017","unstructured":"Muratori P, Efe C, Muratori L et al (2017) Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study. Eur J Gastroenterol Hepatol 29:777\u2013780","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"550_CR95","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/hep.29717","volume":"67","author":"CF Murillo Perez","year":"2018","unstructured":"Murillo Perez CF, Goet JC, Lammers WJ et al (2018) Milder disease stage in patients with primary biliary cholangitis over a 44-year period: a changing natural history. Hepatology 67:1920\u20131930","journal-title":"Hepatology"},{"key":"550_CR96","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1309\/AJCP8D7ILBHPSDOK","volume":"133","author":"V Nair","year":"2010","unstructured":"Nair V, Fischer SE, Adeyi OA (2010) Non-viral-related pathologic findings in liver needle biopsy specimens from patients with chronic viral hepatitis. Am J Clin Pathol 133:127\u2013132","journal-title":"Am J Clin Pathol"},{"key":"550_CR97","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Kondo H, Mori T et al (2007) Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45:118\u2013127","journal-title":"Hepatology"},{"key":"550_CR98","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1600-0676.1988.tb01010.x","volume":"8","author":"Y Nakanuma","year":"1988","unstructured":"Nakanuma Y, Hoso M, Mizuno Y et al (1988) Pathologic study of primary biliary cirrhosis of early histologic stages presenting cholestatic jaundice. Liver 8:319\u2013324","journal-title":"Liver"},{"key":"550_CR99","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/hep.22380","volume":"48","author":"C O\u2019Brien","year":"2008","unstructured":"O\u2019Brien C, Joshi S, Feld JJ et al (2008) Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology 48:550\u2013556","journal-title":"Hepatology"},{"key":"550_CR100","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s00534-012-0521-y","volume":"19","author":"H Ohara","year":"2012","unstructured":"Ohara H, Okazaki K, Tsubouchi H et al (2012) Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci 19:536\u2013542","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"550_CR101","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/jgh.12248","volume":"28","author":"H Ohara","year":"2013","unstructured":"Ohara H, Nakazawa T, Kawa S et al (2013) Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: a Japanese cohort. J Gastroenterol Hepatol 28:1247\u20131251","journal-title":"J Gastroenterol Hepatol"},{"key":"550_CR102","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.cgh.2013.09.021","volume":"12","author":"E Ozaslan","year":"2014","unstructured":"Ozaslan E, Efe C, Heurgue-Berlot A et al (2014) Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. Clin Gastroenterol Hepatol 12:863\u2013869","journal-title":"Clin Gastroenterol Hepatol"},{"key":"550_CR103","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1740-2557-4-3","volume":"4","author":"PA Papamichalis","year":"2007","unstructured":"Papamichalis PA, Zachou K, Koukoulis GK et al (2007) The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis\/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis 4:3","journal-title":"J Autoimmune Dis"},{"key":"550_CR104","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.28256","volume":"63","author":"CY Ponsioen","year":"2016","unstructured":"Ponsioen CY, Chapman RW, Chazouill\u00e8res O et al (2016) Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an International PSC Study Group consensus process. Hepatology 63:1357\u20131367","journal-title":"Hepatology"},{"key":"550_CR105","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/hep.21229","volume":"44","author":"R Poupon","year":"2006","unstructured":"Poupon R, Chazouilleres O, Corpechot C et al (2006) Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis. Hepatology 44:85\u201390","journal-title":"Hepatology"},{"key":"550_CR106","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1365-2893.2005.00642.x","volume":"12","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Pares A, Jara LJ et al (2005) Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature. J Viral Hepat 12:648\u2013654","journal-title":"J Viral Hepat"},{"key":"550_CR107","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1080\/00365520310008746","volume":"39","author":"EI Rigopoulou","year":"2004","unstructured":"Rigopoulou EI, Dalekos GN (2004) Anti-sp100 antibodies in primary biliary cirrhosis. Scand J Gastroenterol 39:406\u2013407","journal-title":"Scand J Gastroenterol"},{"key":"550_CR108","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1517\/17530059.2.6.621","volume":"2","author":"EI Rigopoulou","year":"2008","unstructured":"Rigopoulou EI, Dalekos GN (2008) Molecular diagnostics of primary biliary cirrhosis. Expert Opin Med Diagn 2:621\u2013634","journal-title":"Expert Opin Med Diagn"},{"key":"550_CR109","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/gut.2003.036558","volume":"54","author":"EI Rigopoulou","year":"2005","unstructured":"Rigopoulou EI, Davies ET, Pares A et al (2005) Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 54:528\u2013532","journal-title":"Gut"},{"key":"550_CR110","doi-asserted-by":"publisher","first-page":"577","DOI":"10.4254\/wjh.v5.i10.577","volume":"5","author":"EI Rigopoulou","year":"2013","unstructured":"Rigopoulou EI, Zachou K, Gatselis NK et al (2013) Primary biliary cirrhosis in HBV and HCV patients: clinical characteristics and outcome. World J Hepatol 5:577\u2013583","journal-title":"World J Hepatol"},{"key":"550_CR111","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3109\/15513815.2014.898721","volume":"33","author":"CP Rojas","year":"2014","unstructured":"Rojas CP, Bodicharla R, Campuzano-Zuluanga G et al (2014) Autoimmune hepatitis and primary sclerosing cholangitis in children and adolescents. Fetal Pediatr Pathol 33:202\u2013209","journal-title":"Fetal Pediatr Pathol"},{"key":"550_CR112","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.29293","volume":"66","author":"C Schramm","year":"2017","unstructured":"Schramm C, Eaton J, Ringe KI et al (2017) Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group. Hepatology 66:1675\u20131688","journal-title":"Hepatology"},{"key":"550_CR113","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/00365520802400883","volume":"44","author":"M Shen","year":"2009","unstructured":"Shen M, Zhang F, Zhang X (2009) Pulmonary hypertension in primary biliary cirrhosis: a prospective study in 178 patients. Scand J Gastroenterol 44:219\u2013223","journal-title":"Scand J Gastroenterol"},{"key":"550_CR114","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00535-003-1285-6","volume":"39","author":"M Shibata","year":"2004","unstructured":"Shibata M, Onozuka Y, Morizane T et al (2004) Prevalence of antimitochondrial antibody in Japanese corporate workers in Kanagawa prefecture. J Gastroenterol 39:255\u2013259","journal-title":"J Gastroenterol"},{"key":"550_CR115","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","volume":"102","author":"MG Silveira","year":"2007","unstructured":"Silveira MG, Talwalkar JA, Angulo P et al (2007) Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol 102:1244\u20131250","journal-title":"Am J Gastroenterol"},{"key":"550_CR116","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.dld.2010.12.008","volume":"43","author":"PP Stanich","year":"2011","unstructured":"Stanich PP, Bjornsson E, Gossard AA et al (2011) Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis. Dig Liver Dis 43:309\u2013313","journal-title":"Dig Liver Dis"},{"key":"550_CR117","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.14309\/crj.2018.54","volume":"5","author":"S Sundaram","year":"2018","unstructured":"Sundaram S, Kiran S, Mazumdar S et al (2018) Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis. ACG Case Rep J 5:e54","journal-title":"ACG Case Rep J"},{"key":"550_CR118","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2169\/internalmedicine.53.2250","volume":"53","author":"R Takemoto","year":"2014","unstructured":"Takemoto R, Miyake Y, Harada K et al (2014) Overlap of IgG4-related sclerosing cholangitis and primary biliary cirrhosis. Intern Med 53:1429\u20131433","journal-title":"Intern Med"},{"key":"550_CR119","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jhbp.50","volume":"21","author":"A Tanaka","year":"2014","unstructured":"Tanaka A, Tazuma S, Okazaki K et al (2014) Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci 21:43\u201350","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"550_CR120","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/jhbp.432","volume":"24","author":"A Tanaka","year":"2017","unstructured":"Tanaka A, Tazuma S, Nakazawa T et al (2017) No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan. J Hepatobiliary Pancreat Sci 24:217\u2013225","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"550_CR121","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3892\/etm.2015.2694","volume":"10","author":"M Tomizawa","year":"2015","unstructured":"Tomizawa M, Shinozaki F, Fugo K et al (2015) Anti-mitochondrial M2 antibody-positive autoimmune hepatitis. Exp Ther Med 10:1419\u20131422","journal-title":"Exp Ther Med"},{"key":"550_CR122","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1365-2036.2012.05223.x","volume":"36","author":"PJ Trivedi","year":"2012","unstructured":"Trivedi PJ, Hirschfield GM (2012) Review article: overlap syndromes and autoimmune liver disease. Aliment Pharmacol Ther 36:517\u2013533","journal-title":"Aliment Pharmacol Ther"},{"key":"550_CR123","first-page":"124","volume":"92","author":"JM Turchany","year":"1997","unstructured":"Turchany JM, Uibo R, Kivik T et al (1997) A study of antimitochondrial antibodies in a random population in Estonia. Am J Gastroenterol 92:124\u2013126","journal-title":"Am J Gastroenterol"},{"key":"550_CR124","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1136\/gut.49.2.276","volume":"49","author":"FP Vleggaar","year":"2001","unstructured":"Vleggaar FP, van Buuren HR, Zondervan PE et al (2001) Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant. Gut 49:276\u2013281","journal-title":"Gut"},{"key":"550_CR125","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jaut.2012.10.004","volume":"41","author":"Q Wang","year":"2013","unstructured":"Wang Q, Selmi C, Zhou X et al (2013) Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun 41:140\u2013145","journal-title":"J Autoimmun"},{"issue":"1975\u20131984","key":"550_CR126","first-page":"e8","volume":"152","author":"TJ Weismuller","year":"2017","unstructured":"Weismuller TJ, Trivedi PJ, Bergquist A et al (2017) Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology 152(1975\u20131984):e8","journal-title":"Gastroenterology"},{"key":"550_CR127","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12016-015-8516-5","volume":"50","author":"F Yang","year":"2016","unstructured":"Yang F, Wang Q, Wang Z et al (2016) The natural history and prognosis of primary biliary cirrhosis with clinical features of autoimmune hepatitis. Clin Rev Allergy Immunol 50:114\u2013123","journal-title":"Clin Rev Allergy Immunol"},{"key":"550_CR128","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.clim.2006.01.002","volume":"119","author":"K Zachou","year":"2006","unstructured":"Zachou K, Liaskos C, Rigopoulou E et al (2006) Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol 119:203\u2013212","journal-title":"Clin Immunol"},{"key":"550_CR129","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","volume":"55","author":"K Zachou","year":"2011","unstructured":"Zachou K, Gatselis NK, Papadamou G et al (2011) Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients. J Hepatol 55:636\u2013646","journal-title":"J Hepatol"},{"key":"550_CR130","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/apt.12470","volume":"38","author":"K Zachou","year":"2013","unstructured":"Zachou K, Muratori P, Koukoulis GK et al (2013) Review article: autoimmune hepatitis\u2014current management and challenges. Aliment Pharmacol Ther 38:887\u2013913","journal-title":"Aliment Pharmacol Ther"},{"key":"550_CR131","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/liv.12658","volume":"35","author":"K Zachou","year":"2015","unstructured":"Zachou K, Gampeta S, Gatselis NK et al (2015) Anti-SLA\/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis. Liver Int 35:660\u2013672","journal-title":"Liver Int"},{"key":"550_CR132","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/apt.13584","volume":"43","author":"K Zachou","year":"2016","unstructured":"Zachou K, Gatselis NK, Arvaniti P et al (2016) A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis. Aliment Pharmacol Ther 43:1035\u20131047","journal-title":"Aliment Pharmacol Ther"},{"key":"550_CR133","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jhep.2014.08.002","volume":"61","author":"R Zenouzi","year":"2014","unstructured":"Zenouzi R, Lohse AW (2014) Long-term outcome in PSC\/AIH \u201coverlap syndrome\u201d: does immunosuppression also treat the PSC component? J Hepatol 61:1189\u20131191","journal-title":"J Hepatol"},{"key":"550_CR134","first-page":"148","volume":"10","author":"H Zhang","year":"2015","unstructured":"Zhang H, Li S, Yang J et al (2015) A meta-analysis of ursodeoxycholic acid therapy versus combination therapy with corticosteroids for PBC-AIH-overlap syndrome: evidence from 97 monotherapy and 117 combinations. Prz Gastroenterol 10:148\u2013155","journal-title":"Prz Gastroenterol"},{"key":"550_CR135","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.3748\/wjg.v18.i34.4721","volume":"18","author":"TA Zografos","year":"2012","unstructured":"Zografos TA, Gatselis N, Zachou K et al (2012) Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients. Word J Gastroenterol 18:4721\u20134728","journal-title":"Word J Gastroenterol"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-019-00550-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-019-00550-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-019-00550-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:14Z","timestamp":1704228554000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-019-00550-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":135,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1007\/s00005-019-00550-9","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]},"assertion":[{"value":"27 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors have nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}